|
Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups |
Gomez-Outes A, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas-Castrillon E |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Gomez-Outes A, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas-Castrillon E. Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups. Thrombosis 2013; 2013: 640723 Indexing Status Subject indexing assigned by CRD MeSH Antithrombins; Atrial Fibrillation; Benzimidazoles; Humans; Morpholines; Pyrazoles; Pyridones; Thiophenes; Warfarin; beta-Alanine AccessionNumber 12014008211 Date bibliographic record published 05/02/2014 |
|
|
|